Perrigo (PRGO) Long-Term Deferred Tax (2013 - 2026)
Perrigo (PRGO) reported Long-Term Deferred Tax of $4.7 million for Q1 2026, down 12.96% year-over-year from $5.4 million in Q1 2025, and up 42.42% quarter-over-quarter from $3.3 million in Q4 2025.
Perrigo (PRGO) Long-Term Deferred Tax (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Long-Term Deferred Tax data on file, last reported at $4.7 million in Q1 2026.
- Long-Term Deferred Tax for Q1 2026 came in at $4.7 million, down 12.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.7 million (down 12.96% YoY), and the FY2025 annual result was $3.3 million, down 35.29% from the prior year.
- Long-Term Deferred Tax grew to $4.7 million in Q1 2026 per PRGO's latest filing, from $3.3 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $64.2 million in Q3 2025 and troughed at $3.3 million in Q4 2025.
- A 5-year average of $15.8 million and a median of $6.9 million in 2022 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2022 and 2024: Long-Term Deferred Tax tumbled 88.31% in 2022, then soared 359.02% in 2024.
- A 5-year view of Long-Term Deferred Tax shows it stood at $7.1 million in 2022, then jumped by 263.38% to $25.8 million in 2023, then slumped by 80.23% to $5.1 million in 2024, then slumped by 35.29% to $3.3 million in 2025, then jumped by 42.42% to $4.7 million in 2026.
- Business Quant data shows PRGO's Long-Term Deferred Tax at $4.7 million in Q1 2026, $3.3 million in Q4 2025, and $64.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 4.70 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Sep 27, 2025 | 64.20 Mn |
| Jun 28, 2025 | 48.10 Mn |
| Mar 29, 2025 | 5.40 Mn |
| Dec 31, 2024 | 5.10 Mn |
| Sep 28, 2024 | 22.40 Mn |
| Jun 29, 2024 | 13.80 Mn |
| Mar 30, 2024 | 28.00 Mn |
| Dec 31, 2023 | 25.80 Mn |
| Sep 30, 2023 | 6.80 Mn |
| Jul 1, 2023 | 6.30 Mn |
| Apr 1, 2023 | 6.10 Mn |
| Dec 31, 2022 | 7.10 Mn |
| Oct 1, 2022 | 7.70 Mn |
| Jul 2, 2022 | 6.90 Mn |
| Apr 2, 2022 | 6.70 Mn |
| Dec 31, 2021 | 6.50 Mn |
| Oct 2, 2021 | 40.20 Mn |
| Jul 3, 2021 | 49.00 Mn |